These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 12830006

  • 1. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [Abstract] [Full Text] [Related]

  • 2. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 3. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 7. TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival.
    Gresele P, Binetti BM, Branca G, Clerici C, Asciutti S, Morelli A, Semeraro N, Colucci M.
    Thromb Res; 2008 Oct; 121(6):763-8. PubMed ID: 17915296
    [Abstract] [Full Text] [Related]

  • 8. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.
    Verkleij CJ, Stuijver DJ, van Zaane B, Squizzato A, Brandjes DP, Büller HR, Meijers JC, Gerdes VE.
    Thromb Haemost; 2013 Feb; 109(2):214-20. PubMed ID: 23197299
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
    Kemona-Chetnik I, Kowal K, Kucharewicz I, Pampuch A, Bodzenta-Lukaszyk A.
    Przegl Lek; 2006 Feb; 63(12):1281-5. PubMed ID: 17642140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation.
    Bouma BN, Mosnier LO, Meijers JC, Griffin JH.
    Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Neill EK, Stewart RJ, Schneider MM, Nesheim ME.
    Anal Biochem; 2004 Jul 15; 330(2):332-41. PubMed ID: 15203340
    [Abstract] [Full Text] [Related]

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
    Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M.
    Thromb Haemost; 2004 Mar 15; 91(3):480-6. PubMed ID: 14983223
    [Abstract] [Full Text] [Related]

  • 20. An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Kim PY, Foley J, Hsu G, Kim PY, Nesheim ME.
    Anal Biochem; 2008 Jan 01; 372(1):32-40. PubMed ID: 17967438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.